Universidad Pontificia Bolivariana. Guevara M, Gines P. Hyponatremia in liver cirrhosis: patho- genesis and treatment. Endocrinol Nutr ;57 Suppl 2

Author:Jull Doshura
Language:English (Spanish)
Published (Last):17 June 2009
PDF File Size:13.39 Mb
ePub File Size:1.74 Mb
Price:Free* [*Free Regsitration Required]

The serum-ascites albumin gradient is superior to the exudates-transudate concept in the differential diagnosis of ascites. Ann Intern Med ; Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis.

Hepatology ; Survival and prognostic factors of cirrhotic patients with ascites: a study of outpatients. Am J Gastroenterol ; Diuretic treatment in decompensated cirrhosis and congestive heart failure: effect of posture. Br Med J ; Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis: a randomized controlled clinical trial comparing two diets with different sodium content.

Liver ; Renal sodium retention in cirrhosis: relation to aldosterone and nephron site. Clin Sci ; Diuresis in the ascitic patient: a randomized controlled trial of three regimens.

J Clin Gastroenterol ; 3 Suppl. Randomized comparative study of efficacy of furosemide versus spironolactone in patients with liver cirrhosis and ascities.

Gastroenterology ; A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients. Randomized clinical study of the efficacy amiloride and potassium canreonate in nonazotemic cirrhotic patients with ascites.

A pathophysiogical interpretation of unresponsiveness to spironolactone in a stepped care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients with liver cirrhosis and ascites. Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis: a randomized controlled clinical trail comparing two diets with different sodium content.

Spironolactone-induced hyperchloremic acidosis in cirrhosis. Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema. Cirrhosis and muscle cramps: evidence of a causal relantionship. Effectiveness of quinine in treating muscle cramps: a double blind, placebo controlled, parallel group, multicentre trial.

Int Clin J Pract ; Kugelmas M. Preliminary observation: oral zinc sulphate replacement is effective in treating muscle cramps in cirrhotics patients. J Am Coll Nutr ; A randomized controlled trial of quinidine in the treatment of cirrhotic patients with muscle cramps. J Hepatol ; The management of ascites in cirrhosis: report of the Consensus Conference of the International Ascites Club. Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis.

A randomized double blind trial of spironolactone versus placebo. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated with paracentesis. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites.

Results of a randomized study. Repeated paracentesis and iv albumin infusion to treat tense ascites in cirrhotic patients. A safe alternative therapy. J Hepatol ; 5: Total paracentesis with dextran 40 vs. Paracentesis associated to dextran 40 vs. Arch Gastroenterol ; Treatment of ascites in patients with liver cirrhosis without neither hyponatremia non real renal insufficiency. Results of a randomized study comparing diuretics and punctures compensated by albumin.

Gastroenterol Clin Biol ; The effects of transjugular intrahepatic portosystemic shunt on systemic and renal hemodynamics and sodium homeostasis in cirrhotics patients with refractory ascites. North American Study for the treatment of refractory ascites group. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.

Transjugular intrahepatic portosystemic shunt: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. J Hepatol , A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Eng J Med ; Stent grafts for revision of TIPS stenoses and occlusions: a clinical pilot study.

J Vasc Interv Radiol ; 8: Pathogenesis, diagnosis and treatment of ascites. Oxford textbook of clinical hepatology. New York: Oxford Medical Publications; p.

Paracentesis with infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med ; Treatment of patients with cirrhosis and refractory ascites using LeVeen shunt with titanium tip: comparison with therapeutic paracentesis.

TIPS y ascitis refractaria. Gastroenterol Hepatol ; 27 4 : Prognostic value of spontaneous hyponatremia in cirrhosis with ascites. Am J Dig Dis ; Ishikawa S, Schrier RW. Arginine vasopressin in cirrhosis. Ascites and renal dysfunction in liver disease. Pathogenesis, diagnosis and treatment. Malden, MA: Blackwell Science; , p. Clinical disorders of renal function in cirrhosis with ascites. Roberstson GL, Berl T. Pathophysiology of water metabolism.

The Kidney. Philadelphia: Saunders Company; , p. Molecular mechanism of vasopressin action in the kidney. In: Windhager EE ed. Handbook of physiology. Section 8, renal physiology. New York: Oxford University Press; , p. Antidiuretic hormone and the pathogenesis of water retention in cirrhosis with ascites. Sem Liver Dis ; Hyponatremia in cirrhosis: from pathogenesis to treatment. The role of V2 vasopressin antagonists in hyponatremia. Cardiovascular Res ; Gross P, Palm C. The treatment of hyponatremia using vasopressin antagonists.

Exp Physiol ; 85S: SS. Vasopressin V2 receptor antagonists. Tratamiento actual. Gastroenterol Hepatol ; 4 Suppl 4 : Renal failure associated with demeclocycline in cirrhosis. Ann Int Med ; Aquaretic effect of the kappa-opioid agonist RU in cirrhotic rats with ascites and water retention. Comparison of two aquaretic drugs Niravoline and OPC in cirrhotic rats with ascites and water retention. J Pharmacol Exp Ther ; ; Aquaretic effects of niravoline, a k- opioid agonist, in patients with cirrhosis.

Vasopressin analogs that antagonize antiudiuretic responses by rats to the antidiuretic hormone. Science ; Manning M, Sawyer WH.


2005, Número 3

Rev Col Gastroenterol [online]. ISSN Patients with advanced liver disease may present volume overloads that can lead to the development of dilutional hyponatremia primarily as the result of persistently high levels of antidiuretic hormone. Liver transplantation is the therapy of choice for patients with terminal liver disease. Patient survival time following transplantation is excellent. Dilutional hyponatremia has proven to be a prognostic factor for patients with cirrhosis, and it can even lead to mortality in patients on the waiting list for liver transplantation.


Hiponatremia dilucional y trasplante hepático. Revisión

Hyponatremia is the most common electrolyte disorder in patients with cirrhosis. In dilutional or hypervolemic hyponatremia, serum sodium concentration is reduced, plasma volume is increased although the effective plasma volume is decreased due to marked arterial vasodilation in the splanchnic circulation and extracellular fluid volume is increased, with ascites and edema in the absence of signs of dehydration. This is a result of the marked deterioration in renal excretion of solute-free water, leading to disproportionate water retention in relation to sodium retention. Since hypervolemic hyponatremia is by far the most frequent form of this disorder, the present chapter will concentrate specifically on hypervolemic hyponatremia in cirrhosis.. ISSN: Hyponatremia in liver cirrhosis: pathogenesis and treatment. Descargar PDF.

Related Articles